Kangchen Pharmaceutical\'s announcement on holding a performance briefing for the third quarter of 2024
Announcement of Resolutions of the Second Meeting of Holders of Kangchen Pharmaceutical\'s Phase I Employee Stock Ownership Plan
Kangchen Pharmaceutical: Kangchen Pharmaceutical\'s announcement on shareholders\' partial share pledges
Kangchen Pharmaceutical\'s announcement on shareholders\' partial share pledges
Legal Opinion of Beijing Guofeng Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Beijing Kangchen Pharmaceutical Co., Ltd.
Announcement of Resolutions of Kangchen Pharmaceutical\'s 2024 Second Extraordinary General Meeting of Shareholders
Opinions of Tianfeng Securities Co., Ltd. on the verification of the use of idle funds raised by Beijing Kangchen Pharmaceutical Co., Ltd. for cash management
Kangchen Pharmaceutical\'s announcement on reducing registered capital to notify creditors
Kangchen Pharmaceutical\'s announcement on the use of some idle funds raised for cash management and redemption
Kangchen Pharmaceutical\'s 2024 Third Quarter Report
Announcement of Resolutions of the 13th Meeting of the Fourth Board of Directors of Kangchen Pharmaceutical
Announcement of Resolutions of the 11th Meeting of the Fourth Board of Supervisors of Kangchen Pharmaceutical
Kangchen Pharmaceutical\'s announcement on the use of idle funds raised for cash management
Kangchen Pharmaceutical 2024 Second Extraordinary General Meeting of Shareholders Meeting Materials
Kangchen Pharmaceutical\'s announcement on holding the 2024 semi-annual results briefing
Kangchen Pharmaceutical Investor Relations Activity Record Form - July-September 2024
Kangchen Pharmaceutical: Beijing Kangchen Pharmaceutical Co., Ltd. related transaction management system (revised in September 2024)
Kangchen Pharmaceutical: Kangchen Pharmaceutical\'s announcement on changing the company\'s registered capital and amending the “Articles of Association”
Kangchen Pharmaceutical: Legal Opinion of Beijing Guofeng Law Firm on the 2023 Restricted Stock Incentive Plan of Beijing Kangchen Pharmaceutical Co., Ltd. to repurchase and cancel some restricted stocks
Kangchen Pharmaceutical: Notice on Cancelling the Company\'s Repurchase of Shares in Special Securities Accounts
No Data